Summit X, LLC Verastem, Inc. Transaction History

Summit X, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$1.9 - $2.82 $41,800 - $62,040	-22,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $8,450 - $21,000	5,000 Added 29.41%	22,000 $38,000
Q1 2020 May 13, 2020	BUY	$1.26 - $3.38 $8,820 - $23,660	7,000 Added 70.0%	17,000 $45,000
Q4 2019 Jan 23, 2020	BUY	$0.86 - $1.44 $8,600 - $14,400	10,000 New	10,000 $13,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $573M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.